BioCentury | Jan 10, 2000
Company News

Ligand Inc., Alfa Wassermann S.p.A. sales and marketing update

LGND granted Alfa exclusive long-term marketing and distribution rights in Italy for Ontak denileukin, Panretin gel and capsules for all indications and Targretin gel and capsules for cancer and dermatological diseases. LGND received a $750,000...
Items per page:
1 - 1 of 1
BioCentury | Jan 10, 2000
Company News

Ligand Inc., Alfa Wassermann S.p.A. sales and marketing update

LGND granted Alfa exclusive long-term marketing and distribution rights in Italy for Ontak denileukin, Panretin gel and capsules for all indications and Targretin gel and capsules for cancer and dermatological diseases. LGND received a $750,000...
Items per page:
1 - 1 of 1